Drawing for TELIX PHARMACEUTICALS

USPTO serial 79257540

TELIX PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 6908866Status 700Registered
Filing date
Status date
Registration date
Nov 29, 2022
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TELIX PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew S. Ehard

Andrew S. Ehard MERCHANT & GOULD P.C.P.O. BOX 2910MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products for use in the treatment, prevention, or diagnosis of cancerACTIVE—
010Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing cancer; drug delivery systems for the treatment, prevention, or diagnosis of cancer, namely, applicators for pharmaceutical preparations sold without medication for use in the treatment, prevention, or diagnosis of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 16, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 16, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 29, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2022GPNXNOTIFICATION PROCESSED BY IB—
Aug 24, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 24, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 24, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 10, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Aug 10, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 10, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 10, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 9, 2022LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Aug 9, 2022LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Oct 3, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Aug 24, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 23, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 15, 2021LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Jul 31, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 12, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 12, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 12, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 30, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 30, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 17, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2019RFNTREFUSAL PROCESSED BY IB—
Jun 14, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 14, 2019RFRRREFUSAL PROCESSED BY MPU—
May 30, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2019DOCKASSIGNED TO EXAMINER—
May 14, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
May 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 25, 2019SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance